# Study of Techniques of Subcutaneous Administration of Fluids Enabled by Human Recombinant Hyaluronidase

> **NCT00807885** · PHASE4 · COMPLETED · sponsor: **Baxter Healthcare Corporation** · enrollment: 100 (actual)

## Conditions studied

- Dehydration

## Interventions

- **DRUG:** hylenex-facilitated subcutaneous Lactated Ringer's infusion

## Key facts

- **NCT ID:** NCT00807885
- **Lead sponsor:** Baxter Healthcare Corporation
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2008-12
- **Primary completion:** 2009-01
- **Final completion:** 2009-01
- **Target enrollment:** 100 (ACTUAL)
- **Last updated:** 2011-10-26

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00807885

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00807885, "Study of Techniques of Subcutaneous Administration of Fluids Enabled by Human Recombinant Hyaluronidase". Retrieved via AI Analytics 2026-07-20 from https://api.ai-analytics.org/clinical/NCT00807885. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*